| Literature DB >> 31673442 |
Azin Niazi1, Vafa Baradaran Rahimi1,2, Hooman Hatami1, Reza Shirazinia3, Reza Esmailzadeh-Dizaji4, Nafiseh Askari5, Vahid Reza Askari1,2,6.
Abstract
INTRODUCTION: Mastalgia is the most common benign breast disorder during the fertility period of women. So far a wide range of natural or complementary medicines is used to cure mastalgia. Sanitary organizations need complete and suitable details to help women, for making the proper decision for alternative treatment based on the evidence. The aim of the present study is to introduce medicinal plant-based treatments about mastalgia and summarizes clinical trials about this disorder.Entities:
Keywords: breast pain; herbal medicine; mastalgia
Year: 2019 PMID: 31673442 PMCID: PMC6820470 DOI: 10.3831/KPI.2019.22.017
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Trials in the treatment of cyclic mastalgia
| References | Location | Author/year | Method | Research society | Intervention group/group1 | Control group/group2 | Tools |
|---|---|---|---|---|---|---|---|
| Tehran | Mirmolaei (2017) | Triple-blind clinical trial | 72 women with cyclic mastalgia | Oral paraffin syrup, 10 ml/day, equivalent to two spoons. | Mc Gill, VAS | ||
| Tehran | Mirmolaei (2015) | Triple-blind clinical trial | 99 women with cyclic mastalgia | Oral paraffin syrup 33 people, Evaluation two months before the intervention until three months after treatment | Mc Gill, VAS | ||
| Tehran | Mirmolaei (2016) | Triple-blind clinical trial | 72women with cyclic mastalgia | First group: | second group: Oral paraffin syrup 33 people, Evaluation two months before the intervention up to three months after treatment | Mc Gill, VAS | |
| Yazd | Sekhavat (2009) | Double-blind clinical trial | 117women with cyclic mastalgia | Placebo | NAM | ||
| Paraguay | Halaska (1999) | Double-blind clinical trial | 97women with cyclic mastalgia | Placebo | VAS, | ||
| Qaem Shahr | Alvandi (2010) | Double-blind clinical trial | 100 women with cyclic mastalgia | Placebo | Mc Gill | ||
| Arak | Salehi (2013) | Triple-blind clinical trial | 210women with cyclic mastalgia | First group | Control group: a 400-unit Vitamin E capsule daily for two months | NAM, Cardiff chart | |
| Mashhad | Jaafarnejad (2016) | Clinical trial | 90women with cyclic mastalgia | First group: | - | VAS | |
| Shiraz | Vaziri (2014) | Clinical trial | 180women with cyclic mastalgia | First group: | Control group: wheat bread | VAS | |
| Shahr e Kord | Delaram (2011) | Clinical trial | 60 people | 30drops | Control group: Placebo | DSRP | |
| Shahr e Kord | Delaram (2011) | Clinical trial | 90 people | First group: 30 drops | Control group: Placebo | DSRP | |
| Tehran | Khayat (2015) | Clinical trial | 70 people | Curcumin powder Capsule 7 days before till 3 days after Menstruation two times a day for 3 consecutive cycles | Control group: 50 mg starch capsule | DSRP | |
| Kazerun | Sharifi (2014) | Clinical trial | 90 people | 5%Curcumin Capsule from 21th day of Menstruation cycle till the start of next period, three times a day for two consecutive cycles | Control group: Mefenamic acid capsule from the 21st day of Menstruation cycle till the start of next period, three times a day for two consecutive cycles | DSRP | |
| Tehran | Khayat (2016) | Clinical trial | 105 people | First group: two Zintoma capsules daily, | Control group: Placebo capsule contains 50 mg starch | DSRP | |
| Tehran | Pakgohar (2005) | Clinical trial | 70 people | 30 drops Hypiran two times a day | Control group: Placebo drop | DSRP | |
| Arak | Jamilian (2017) | Clinical trial | 120 people | First group: A Omeg3 500mg capsule per day Second group: 30 drops | Control group: Placebo drop | DSRP | |
| Jahrom | Ataollahi (2015) | Clinical trial | 100 people | Wheat Germ 400mg capsule from 16th Menstruation cycle to the 5th day of next cycle for two consecutive Months | Placebo | DSRP | |
| Tehran | Ozgoli (2010) | Clinical trial | 80 people | 10 drops of | Placebo | DSRP | |
| Paris | Tamborini (1993) | clinical trial | 165 people | standardized | Placebo | DSRP |